by admin | Jan 30, 2016 | Uncategorized
January 21,2016- FDA awards ENB lead product ENB001 Orphan Drug Designation for Stage IIB- Stage IV melanoma. This represents a major milestone in our development program for ENB001 which now qualifies for various development incentives including tax credits for...
by admin | Jan 9, 2016 | Uncategorized
December, 2015. Biotech Showcase™ is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during...
by admin | Jan 9, 2016 | Uncategorized
November, 2015 The Life Sciences Summit is an early stage investor and business development conference that highlights innovation. The pipeline café features academic innovators who are hand selected to present their discoveries, which are available for partnering....
by admin | Jun 9, 2015 | Uncategorized
Welcome to ENB Therapeutics. We believe that there are serious deficits in current melanoma therapies. It is our goal to offer better and more cost effective solutions for a devastating disease.
